Synta Pharmaceuticals (SNTA) Misses Q1 Loss Views by 2c/Share
Tweet
Share
E-mailGet Alerts SNTA Hot Sheet
Price: $0.34 --0%
Financial Fact:
Loss from operations: -14.09M
Today's EPS Names:
ARDS, SQZB, MDRX, More
Financial Fact:
Loss from operations: -14.09M
Today's EPS Names:
ARDS, SQZB, MDRX, More
Join SI Premium – FREE
Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) reported Q1 EPS of ($0.27), $0.02 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $100 thousand versus the consensus estimate of $660 thousand.
For earnings history and earnings-related data on Synta Pharmaceuticals, Inc. (SNTA) click here.
For earnings history and earnings-related data on Synta Pharmaceuticals, Inc. (SNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Strattec Security Corp (STRT) Tops Q4 EPS by 94c
- Semtech (SMTC) Tops Q2 EPS by 10c, Beats on Revenue; Offers Q3 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
